Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation
NCT00492869
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Transplantation
Interventions
DRUG:
AEB071
Sponsor
Novartis Pharmaceuticals